The US Food and Drug Administration (FDA) is planning to regulate the use of the cannabis compound CBD in food and supplements after weighing the evidence on the compound's safety.
The FDA will decide whether regulating legal cannabis will require new agency rules or new legislation from Congress.
Cannabis products, excluding Epidiolex, are illegal at the federal level in the US, although some states allow their use.
According to Patrick Cournoyer, who heads the FDA office developing the agency's cannabis strategy, the FDA will ascertain if CBD can be safely eaten every day for a long period or during pregnancy amid concerns about future fertility.
.


Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Trump Lawsuit Against JPMorgan Signals Rising Tensions Between Wall Street and the White House
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Supreme Court Signals Skepticism Toward Hawaii Handgun Carry Law
Minnesota Judge Rejects Bid to Halt Trump Immigration Enforcement in Minneapolis
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Trump Family Files $10 Billion Lawsuit Over IRS Tax Disclosure
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations 



